Showing results (181-190 of 445) with videos related to
Sort By:
Pageof 45
Journal of Endocrinological Investigation|October 10, 2007
Symptomatic hypoglycemia during imatinib mesylate in a non-diabetic female patient with gastrointestinal stromal tumorM Haap, B Gallwitz, C Thamer, et al.Scientific Reports|February 22, 2024
Mass irradiation of adult Aedes mosquitoes using a coolable 3D printed canisterF Balestrino, N S Bimbilé Somda, M Samuel, et al.Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|June 10, 2009
What is the value of routine follow-up in stage I seminoma after paraaortic radiotherapy?: an analysis of the German Testicular Cancer Study Group (GTCSG) in 675 prospectively followed patientsJohannes Clasen, Heinz Schmidberger, Rainer Souchon, et al.Journal of Cancer Research and Clinical Oncology|October 1, 2008
Four consecutive multicenter phase II trials of adjuvant chemoradiation in patients with completely resected high-risk gastric cancer: the experience of the German AIO/ARO/CAO groupKarin Oechsle, Carsten Bokemeyer, Jörg T Hartmann, et al.Anti-Cancer Drugs|April 11, 2000
The use of reduced doses of amifostine to ameliorate nephrotoxicity of cisplatin/ifosfamide-based chemotherapy in patients with solid tumorsJ T Hartmann, S Knop, L M Fels, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 14, 2009
High-dose chemotherapy (HDCT) as second-salvage treatment in patients with multiple relapsed or refractory germ-cell tumorsA Lorch, A Neubauer, M Hackenthal, et al.Investigational New Drugs|July 6, 2012
Pemetrexed in patients with refractory soft tissue sarcoma: a non-comparative multicenter phase II study of the German Sarcoma Group AIO-STS 005J T Hartmann, S Bauer, G Egerer, et al.Investigational New Drugs|September 1, 2005
An open label, non-comparative phase II study of gemcitabine as salvage treatment for patients with pretreated adult type soft tissue sarcomaJ T Hartmann, K Oechsle, J Huober, et al.Anesthesiology|September 15, 1999
A new noninvasive method to measure blood pressure: results of a multicenter trialK Belani, M Ozaki, J Hynson, et al.Anti-Cancer Drugs|February 1, 2007
An open-label, multicenter phase II trial of capecitabine in patients with cisplatin-refractory or relapsed germ cell tumorsKarin Oechsle, Friedemann Honecker, Christian Kollmannsberger, et al.Pageof 45